Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia. [electronic resource]
Producer: 20110926Description: 528-36 p. digitalISSN:- 1521-0103
- Adult
- Aged
- Aged, 80 and over
- Animals
- Cell Proliferation -- drug effects
- Drug Delivery Systems -- methods
- Humans
- Intermediate-Conductance Calcium-Activated Potassium Channels -- antagonists & inhibitors
- Male
- Middle Aged
- Potassium Channel Blockers -- administration & dosage
- Potassium Channels, Calcium-Activated -- antagonists & inhibitors
- Prostatic Hyperplasia -- drug therapy
- Pyrazoles -- administration & dosage
- Rats
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.